Distress before chemotherapy predicts delayed but not acute nausea
- 3 August 2006
- journal article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 15 (2), 171-177
- https://doi.org/10.1007/s00520-006-0113-y
Abstract
Posttreatment nausea (PTN) is a common side effect of cytotoxic cancer chemotherapy. Previous retrospective research has suggested that the severity of PTN may be, in part, related to pretreatment psychological factors (e.g., emotional distress and expectations for nausea). The purpose of the present study was to examine these relationships prospectively, with distress and nausea expectations assessed by validated self-report measures completed in the clinic before the participants’ first outpatient treatment infusion and with PTN (0–100) assessed by end-of-day diaries completed at home on each of the first 5 days after treatment. The participants were chemotherapy-naive women (N=56) scheduled for standard adjuvant treatment for stage I–II breast cancer (mean age=45.6 years). PTN was evaluated for acute (days 0–1) and delayed (days 2–5) responses. The results revealed a significant relationship between pretreatment distress and the severity of the patients’ subsequent delayed nausea (pp<0.19). No significant relationships were seen between expectations and PTN. However, there was evidence of an additive effect of nausea expectations and distress, with the highest levels of delayed PTN seen in patients with both expectations and higher distress before treatment. The results suggest a selective effect of pre-infusion psychological variables on the delayed phase of nausea after chemotherapy, consistent with an emerging view that the different phases of nausea are mediated by different neural pathways. Future research should examine the possibility that delayed nausea, which the literature suggests is more resistant to antiemetic drugs than acute nausea, might be responsive to psychological interventions before initial treatments.Keywords
This publication has 37 references indexed in Scilit:
- Update on anti‐emetics for chemotherapy‐induced emesisInternal Medicine Journal, 2005
- The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trialsEuropean Journal of Cancer, 2005
- Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancerSupportive Care in Cancer, 2004
- Patient expectation is a strong predictor of severe nausea after chemotherapyCancer, 2004
- Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonistsEuropean Journal of Cancer, 2003
- Delayed Chemotherapy-Induced Nausea in Women Treated for Breast CancerOncology Nursing Forum, 2003
- Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patientsSupportive Care in Cancer, 2002
- Nausea and Vomiting Remain a Significant Clinical Problem: Trends Over Time in Controlling Chemotherapy-Induced Nausea and Vomiting in 1413 Patients Treated in Community Clinical PracticesJournal of Pain and Symptom Management, 2000
- The application of a shortened version of the profile of mood states in a sample of breast cancer chemotherapy patientsBritish Journal of Health Psychology, 1999
- Postchemotherapy Nausea and Vomiting in Cancer Patients Receiving outpatient ChemotherapyJournal of Psychosocial Oncology, 1991